BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15327776)

  • 41. Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system.
    Reuter T; Herterich S; Bernhard O; Hoehn H; Gross HJ
    Blood; 2000 Jan; 95(2):719-20. PubMed ID: 10627486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2.
    Zahnreich S; Weber B; Rösch G; Schindler D; Schmidberger H
    DNA Repair (Amst); 2020 Dec; 96():102992. PubMed ID: 33069004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery.
    Thompson LH; Hinz JM; Yamada NA; Jones NJ
    Environ Mol Mutagen; 2005; 45(2-3):128-42. PubMed ID: 15668941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The interplay of Fanconi anemia proteins in the DNA damage response.
    Wang X; D'Andrea AD
    DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA.
    Pang Q; Keeble W; Diaz J; Christianson TA; Fagerlie S; Rathbun K; Faulkner GR; O'Dwyer M; Bagby GC
    Blood; 2001 Mar; 97(6):1644-52. PubMed ID: 11238103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
    van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
    Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Fanconi anemia pathway: insights from somatic cell genetics using DT40 cell line.
    Takata M; Ishiai M; Kitao H
    Mutat Res; 2009 Jul; 668(1-2):92-102. PubMed ID: 19622405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination.
    Yamamoto K; Hirano S; Ishiai M; Morishima K; Kitao H; Namikoshi K; Kimura M; Matsushita N; Arakawa H; Buerstedde JM; Komatsu K; Thompson LH; Takata M
    Mol Cell Biol; 2005 Jan; 25(1):34-43. PubMed ID: 15601828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cloning and analysis of the murine Fanconi anemia group C cDNA.
    Wevrick R; Clarke CA; Buchwald M
    Hum Mol Genet; 1993 Jun; 2(6):655-62. PubMed ID: 7689006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional interplay between BRCA2/FancD1 and FancC in DNA repair.
    Kitao H; Yamamoto K; Matsushita N; Ohzeki M; Ishiai M; Takata M
    J Biol Chem; 2006 Jul; 281(30):21312-21320. PubMed ID: 16687415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.
    Hoatlin ME; Zhi Y; Ball H; Silvey K; Melnick A; Stone S; Arai S; Hawe N; Owen G; Zelent A; Licht JD
    Blood; 1999 Dec; 94(11):3737-47. PubMed ID: 10572087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BIK (NBK) is a mediator of the sensitivity of Fanconi anaemia group C lymphoblastoid cell lines to interstrand DNA cross-linking agents.
    Prieto-Remón I; Sánchez-Carrera D; López-Duarte M; Richard C; Pipaón C
    Biochem J; 2012 Nov; 448(1):153-63. PubMed ID: 22873408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of non-homologous end joining in Fanconi Anemia cells results in rescue of survival after interstrand crosslinks but sensitization to replication associated double-strand breaks.
    Eccles LJ; Bell AC; Powell SN
    DNA Repair (Amst); 2018 Apr; 64():1-9. PubMed ID: 29459202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parallel genome-wide screens identify synthetic viable interactions between the BLM helicase complex and Fanconi anemia.
    Moder M; Velimezi G; Owusu M; Mazouzi A; Wiedner M; Ferreira da Silva J; Robinson-Garcia L; Schischlik F; Slavkovsky R; Kralovics R; Schuster M; Bock C; Ideker T; Jackson SP; Menche J; Loizou JI
    Nat Commun; 2017 Nov; 8(1):1238. PubMed ID: 29089570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Progress of research on protein composition and gene therapy of Fanconi anaemia - review].
    Li ZY; Zou YF; Deng YB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):231-5. PubMed ID: 15157341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA cross-link repair protein SNM1A interacts with PIAS1 in nuclear focus formation.
    Ishiai M; Kimura M; Namikoshi K; Yamazoe M; Yamamoto K; Arakawa H; Agematsu K; Matsushita N; Takeda S; Buerstedde JM; Takata M
    Mol Cell Biol; 2004 Dec; 24(24):10733-41. PubMed ID: 15572677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
    van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
    Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Fanconi anemia core complex forms four complexes of different sizes in different subcellular compartments.
    Thomashevski A; High AA; Drozd M; Shabanowitz J; Hunt DF; Grant PA; Kupfer GM
    J Biol Chem; 2004 Jun; 279(25):26201-9. PubMed ID: 15082718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Fanconi anemia ID2 complex: dueling saxes at the crossroads.
    Boisvert RA; Howlett NG
    Cell Cycle; 2014; 13(19):2999-3015. PubMed ID: 25486561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Fanconi anemia protein interaction network: casting a wide net.
    Rego MA; Kolling FW; Howlett NG
    Mutat Res; 2009 Jul; 668(1-2):27-41. PubMed ID: 19101576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.